This information is current as Signaling Pathways APOBEC 3 mRNA through Different and Lipopolysaccharide Upregulate α IFN -

[1]  Bingqing Xia,et al.  Lyn is involved in CD24-induced ERK1/2 activation in colorectal cancer , 2012, Molecular Cancer.

[2]  S. Estrem,et al.  Reactivation of Mitogen-activated Protein Kinase (MAPK) Pathway by FGF Receptor 3 (FGFR3)/Ras Mediates Resistance to Vemurafenib in Human B-RAF V600E Mutant Melanoma* , 2012, The Journal of Biological Chemistry.

[3]  P. Jones,et al.  A novel role for APOBEC3: Susceptibility to sexual transmission of murine acquired immunodeficiency virus (mAIDS) is aggravated in APOBEC3 deficient mice , 2012, Retrovirology.

[4]  L. Travassos,et al.  Jacaranone Induces Apoptosis in Melanoma Cells via ROS-Mediated Downregulation of Akt and p38 MAPK Activation and Displays Antitumor Activity In Vivo , 2012, PloS one.

[5]  S. Mansouri,et al.  Pokeweed Antiviral Protein Increases HIV-1 Particle Infectivity by Activating the Cellular Mitogen Activated Protein Kinase Pathway , 2012, PloS one.

[6]  S. Okada,et al.  HIV-1 Proteins Preferentially Activate Anti-Inflammatory M2-Type Macrophages , 2012, The Journal of Immunology.

[7]  S. Shang,et al.  HCMV-encoded UL128 enhances TNF-α and IL-6 expression and promotes PBMC proliferation through the MAPK/ERK pathway in vitro. , 2012, Viral immunology.

[8]  P. Jones,et al.  Bone marrow stromal cell antigen 2 (BST-2) restricts mouse mammary tumor virus (MMTV) replication in vivo , 2012, Retrovirology.

[9]  H. Ren,et al.  Interferon alpha regulates MAPK and STAT1 pathways in human hepatoma cells , 2011, Virology Journal.

[10]  A. Planas,et al.  Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88‐dependent NFκB signaling, MAPK, and Jak1/Stat1 pathways , 2011, Glia.

[11]  M. Feldman,et al.  APOBEC3 proteins expressed in mammary epithelial cells are packaged into retroviruses and can restrict transmission of milk-borne virions. , 2010, Cell host & microbe.

[12]  Hui Chen,et al.  Interferon-alpha Induces High Expression of APOBEC3G and STAT-1 in Vitro and in Vivo , 2010, International journal of molecular sciences.

[13]  P. Dixon,et al.  Identification of JAK-STAT pathways as important for the anti-inflammatory activity of a Hypericum perforatum fraction and bioactive constituents in RAW 264.7 mouse macrophages. , 2010, Phytochemistry.

[14]  M. McElrath,et al.  Polymorphisms in toll-like receptor 4 and toll-like receptor 9 influence viral load in a seroincident cohort of HIV-1-infected individuals , 2009, AIDS.

[15]  Y. Xiong,et al.  A Single Amino Acid Difference in Human APOBEC3H Variants Determines HIV-1 Vif Sensitivity , 2009, Journal of Virology.

[16]  M. McElrath,et al.  Human Immunodeficiency Virus Type 1 Mediates Global Disruption of Innate Antiviral Signaling and Immune Defenses within Infected Cells , 2009, Journal of Virology.

[17]  M. Malim,et al.  Defining APOBEC3 Expression Patterns in Human Tissues and Hematopoietic Cell Subsets , 2009, Journal of Virology.

[18]  M. Glogauer,et al.  Adaptor Protein SLAT Modulates Fcγ Receptor-mediated Phagocytosis in Murine Macrophages* , 2009, Journal of Biological Chemistry.

[19]  C. Ehrhardt,et al.  High level expression of the anti-retroviral protein APOBEC3G is induced by influenza A virus but does not confer antiviral activity , 2009, Retrovirology.

[20]  B. Peterlin,et al.  Enhanced replication and pathogenesis of Moloney murine leukemia virus in mice defective in the murine APOBEC3 gene. , 2009, Virology.

[21]  B. Peterlin,et al.  Induction of APOBEC3 In Vivo Causes Increased Restriction of Retrovirus Infection , 2009, Journal of Virology.

[22]  S. Ross,et al.  Expression of Murine APOBEC3 Alleles in Different Mouse Strains and Their Effect on Mouse Mammary Tumor Virus Infection , 2009, Journal of Virology.

[23]  D. Kolson,et al.  Expression and regulation of antiviral protein APOBEC3G in human neuronal cells , 2009, Journal of Neuroimmunology.

[24]  C. Tian,et al.  Sole copy of Z2‐type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV‐1. , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[25]  H. Chi,et al.  Acetylation of MKP-1 and the Control of Inflammation , 2008, Science Signaling.

[26]  Ruslan Medzhitov,et al.  HIV immunology needs a new direction , 2008, Nature.

[27]  M. Emerman,et al.  Antiretroelement activity of APOBEC3H was lost twice in recent human evolution. , 2008, Cell host & microbe.

[28]  T. Kawamoto,et al.  TAK-242 selectively suppresses Toll-like receptor 4-signaling mediated by the intracellular domain. , 2008, European journal of pharmacology.

[29]  Shu Zheng,et al.  Association of human APOBEC3 cytidine deaminases with the generation of hepatitis virus B x antigen mutants and hepatocellular carcinoma , 2007, Hepatology.

[30]  S. Ross,et al.  A Novel Block to Mouse Mammary Tumor Virus Infection of Lymphocytes in B10.BR Mice , 2007, Journal of Virology.

[31]  Wei Zhang,et al.  Cytidine deaminase APOBEC3B interacts with heterogeneous nuclear ribonucleoprotein K and suppresses hepatitis B virus expression , 2007, Cellular microbiology.

[32]  M. Cobb,et al.  Differential regulation of CHOP-10/GADD153 gene expression by MAPK signaling in pancreatic β-cells , 2007, Proceedings of the National Academy of Sciences.

[33]  Xiao-Fang Yu,et al.  Cell-specific regulation of APOBEC3F by interferons. , 2007, Acta biochimica et biophysica Sinica.

[34]  B. Peterlin,et al.  APOBEC3 inhibits mouse mammary tumour virus replication in vivo , 2007, Nature.

[35]  M. Malim,et al.  APOBEC3F Can Inhibit the Accumulation of HIV-1 Reverse Transcription Products in the Absence of Hypermutation , 2007, Journal of Biological Chemistry.

[36]  R. Steinman,et al.  APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection , 2006, The Journal of experimental medicine.

[37]  W. Greene,et al.  Distinct Patterns of Cytokine Regulation of APOBEC3G Expression and Activity in Primary Lymphocytes, Macrophages, and Dendritic Cells* , 2006, Journal of Biological Chemistry.

[38]  Rongzhen Xu,et al.  STAT1-Independent Cell Type-Specific Regulation of Antiviral APOBEC3G by IFN-α1 , 2006, The Journal of Immunology.

[39]  J. Löwer,et al.  APOBEC3 Proteins Inhibit Human LINE-1 Retrotransposition* , 2006, Journal of Biological Chemistry.

[40]  M. Fenton,et al.  TLR2- and TLR4-dependent activation of STAT1 serine phosphorylation in murine macrophages is protein kinase C-δ-independent , 2006, Journal of endotoxin research.

[41]  S. Wain-Hobson,et al.  Interferon‐inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication , 2006, Hepatology.

[42]  Deborah Chavez,et al.  Genomic response to interferon‐α in chimpanzees: Implications of rapid downregulation for hepatitis C kinetics , 2006, Hepatology.

[43]  W. Greene,et al.  Endogenous factors enhance HIV infection of tissue naive CD4 T cells by stimulating high molecular mass APOBEC3G complex formation , 2006, The Journal of experimental medicine.

[44]  C. Lilley,et al.  APOBEC3A Is a Potent Inhibitor of Adeno-Associated Virus and Retrotransposons , 2006, Current Biology.

[45]  H. Chi,et al.  Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[46]  M. Fischl,et al.  Interferon-α2b With Protease Inhibitor-Based Antiretroviral Therapy in Patients With AIDS-Associated Kaposi Sarcoma: An AIDS Malignancy Consortium Phase I Trial , 2006, Journal of acquired immune deficiency syndromes.

[47]  S. Wahl,et al.  Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti–HIV-1 activity , 2006, The Journal of experimental medicine.

[48]  H. S. Warren,et al.  Toll-like receptors. , 2005, Critical care medicine.

[49]  Baofeng Yang,et al.  MAPK/AP-1-dependent regulation of PAI-1 gene expression by TGF-beta in rat mesangial cells. , 2005, Kidney international.

[50]  Yusen Liu,et al.  The Function of Mitogen-activated Protein Kinase Phosphatase-1 in Peptidoglycan-stimulated Macrophages* , 2004, Journal of Biological Chemistry.

[51]  R. König,et al.  APOBEC3B and APOBEC3C Are Potent Inhibitors of Simian Immunodeficiency Virus Replication* , 2004, Journal of Biological Chemistry.

[52]  Xianghui Yu,et al.  Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines. , 2004, Genes & development.

[53]  K. Triantafilou,et al.  Coxsackievirus B4-Induced Cytokine Production in Pancreatic Cells Is Mediated through Toll-Like Receptor 4 , 2004, Journal of Virology.

[54]  M. Marin,et al.  Transcriptional Regulation of APOBEC3G, a Cytidine Deaminase That Hypermutates Human Immunodeficiency Virus* , 2004, Journal of Biological Chemistry.

[55]  D. Portnoy,et al.  Mice Lacking the Type I Interferon Receptor Are Resistant to Listeria monocytogenes , 2004, The Journal of experimental medicine.

[56]  M. Malim,et al.  Cytidine Deamination of Retroviral DNA by Diverse APOBEC Proteins , 2004, Current Biology.

[57]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[58]  S. Batalov,et al.  A gene atlas of the mouse and human protein-encoding transcriptomes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[59]  B. Strack,et al.  Vif Overcomes the Innate Antiviral Activity of APOBEC3G by Promoting Its Degradation in the Ubiquitin-Proteasome Pathway* , 2004, Journal of Biological Chemistry.

[60]  R. Everett,et al.  The Herpes Simplex Virus ICP0 RING Finger Domain Inhibits IRF3- and IRF7-Mediated Activation of Interferon-Stimulated Genes , 2004, Journal of Virology.

[61]  S. Ross,et al.  Toll-Like Receptor 4-Dependent Activation of Dendritic Cells by a Retrovirus , 2004, Journal of Virology.

[62]  Reuben S Harris,et al.  The Vif Protein of HIV Triggers Degradation of the Human Antiretroviral DNA Deaminase APOBEC3G , 2003, Current Biology.

[63]  Yunkai Yu,et al.  Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex , 2003, Science.

[64]  M. Malim,et al.  The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif , 2003, Nature Medicine.

[65]  M. Marin,et al.  HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation , 2003, Nature Medicine.

[66]  W. Greene,et al.  HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. , 2003, Molecular cell.

[67]  E. Moilanen,et al.  c-Jun NH2-terminal kinase inhibitor anthra(1,9-cd)pyrazol-6(2H)-one reduces inducible nitric-oxide synthase expression by destabilizing mRNA in activated macrophages. , 2003, Molecular pharmacology.

[68]  H. Klenk,et al.  The Ebola Virus VP35 Protein Inhibits Activation of Interferon Regulatory Factor 3 , 2003, Journal of Virology.

[69]  Hui Zhang,et al.  The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA , 2003, Nature.

[70]  Gersende Caron,et al.  Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts , 2003, Nature.

[71]  S. Rhee,et al.  Toll-like Receptors 2 and 4 Activate STAT1 Serine Phosphorylation by Distinct Mechanisms in Macrophages* , 2003, Journal of Biological Chemistry.

[72]  M. Malim,et al.  DNA Deamination Mediates Innate Immunity to Retroviral Infection , 2003, Cell.

[73]  F. Clavel,et al.  Hypermutation of HIV-1 DNA in the Absence of the Vif Protein , 2003, Science.

[74]  Stanley M. Lemon,et al.  Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease , 2003, Science.

[75]  C. Sousa.  Faculty Opinions recommendation of TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. , 2003 .

[76]  T. Akazawa,et al.  TICAM-1, an adaptor molecule that participates in Toll-like receptor 3–mediated interferon-β induction , 2003, Nature Immunology.

[77]  S. Akira,et al.  Toll-like Receptors and Their Signaling Mechanisms , 2003, Scandinavian journal of infectious diseases.

[78]  S. Akira,et al.  Cutting Edge: A Novel Toll/IL-1 Receptor Domain-Containing Adapter That Preferentially Activates the IFN-β Promoter in the Toll-Like Receptor Signaling1 , 2002, The Journal of Immunology.

[79]  G. Johnson,et al.  Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases , 2002, Science.

[80]  S. Akira,et al.  Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4 , 2002, Nature.

[81]  Govinda Rao,et al.  IRF3 mediates a TLR3/TLR4-specific antiviral gene program. , 2002, Immunity.

[82]  Sang -Geon Kim,et al.  JunB/AP-1 and NF-kappa B-mediated induction of nitric oxide synthase by bovine type I collagen in serum-stimulated murine macrophages. , 2002, Nitric oxide : biology and chemistry.

[83]  C. Brosnan,et al.  Role of mitogen-activated protein kinases in inducible nitric oxide synthase and TNFα expression in human fetal astrocytes , 2002, Journal of Neuroimmunology.

[84]  S. Ross,et al.  Murine retroviruses activate B cells via interaction with toll-like receptor 4 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[85]  L. Anderson,et al.  Involvement of Toll-Like Receptor 4 in Innate Immunity to Respiratory Syncytial Virus , 2001, Journal of Virology.

[86]  R. Flavell,et al.  Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.

[87]  E. Chan,et al.  Induction of Inducible Nitric Oxide Synthase-NO· by Lipoarabinomannan ofMycobacterium tuberculosis Is Mediated by MEK1-ERK, MKK7-JNK, and NF-κB Signaling Pathways , 2001, Infection and Immunity.

[88]  Douglas T. Golenbock,et al.  Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus , 2000, Nature Immunology.

[89]  L. Platanias,et al.  Activation of the p38 Mitogen-activated Protein Kinase by Type I Interferons , 1999 .

[90]  Lin,et al.  Involvement of p38 mitogen‐activated protein kinase in lipopolysaccharide‐induced iNOS and COX‐2 expression in J774 macrophages , 1999, Immunology.

[91]  C. Chen,et al.  p38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages. , 1999, Molecular pharmacology.

[92]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[93]  R. Buller,et al.  Vaccinia Virus B18R Gene Encodes a Type I Interferon-binding Protein That Blocks Interferon α Transmembrane Signaling (*) , 1995, The Journal of Biological Chemistry.

[94]  J. Darnell,et al.  Tyrosine-phosphorylated Stat1 and Stat2 plus a 48-kDa protein all contact DNA in forming interferon-stimulated-gene factor 3. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[95]  H. Gendelman,et al.  Alpha interferon-induced antiretroviral activities: restriction of viral nucleic acid synthesis and progeny virion production in human immunodeficiency virus type 1-infected monocytes , 1994, Journal of virology.

[96]  L. Platanias,et al.  Tyrosine phosphorylation of the alpha and beta subunits of the type I interferon receptor. Interferon-beta selectively induces tyrosine phosphorylation of an alpha subunit-associated protein. , 1994, The Journal of biological chemistry.

[97]  M Aguet,et al.  Functional role of type I and type II interferons in antiviral defense. , 1994, Science.

[98]  J. Darnell,et al.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.

[99]  F. Marks,et al.  Rottlerin, a novel protein kinase inhibitor. , 1994, Biochemical and biophysical research communications.

[100]  W. Walker,et al.  Immortalization of cloned mouse splenic macrophages with a retrovirus containing the v-raf/mil and v-myc oncogenes. , 1988, Cellular immunology.

[101]  Y. Nishizuka,et al.  The common structure and activities of four subspecies of rat brain protein kinase C family , 1987, FEBS letters.

[102]  A. Sodhi,et al.  Protein kinase Cdelta and protein tyrosine kinase regulate peptidoglycan-induced nuclear factor-kappaB activation and inducible nitric oxide synthase expression in mouse peritoneal macrophages in vitro. , 2010, Molecular immunology.

[103]  K. Mossman,et al.  Characterization of the interferon regulatory factor 3-mediated antiviral response in a cell line deficient for IFN production. , 2009, Molecular immunology.

[104]  Sun-Hee Kim,et al.  Effect of rottlerin, a PKC-delta inhibitor, on TLR-4-dependent activation of murine microglia. , 2005, Biochemical and biophysical research communications.

[105]  Chen Dong,et al.  MAP kinases in the immune response. , 2002, Annual review of immunology.

[106]  E. Chan,et al.  IFN-gamma + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38(mapk) in a mouse macrophage cell line. , 2001, American journal of physiology. Cell physiology.

[107]  G. Kollias,et al.  TNF-alpha induction by LPS is regulated posttranscriptionally via a Tpl2/ERK-dependent pathway. , 2000, Cell.

[108]  S. Uh,et al.  Evaluation of the role of mitogen-activated protein kinases in the expression of inducible nitric oxide synthase by IFN-gamma and TNF-alpha in mouse macrophages. , 1999, Journal of immunology.

[109]  A. Morrison,et al.  Both p38alpha(MAPK) and JNK/SAPK pathways are important for induction of nitric-oxide synthase by interleukin-1beta in rat glomerular mesangial cells. , 1999, The Journal of biological chemistry.

[110]  T. Arora,et al.  Dissociation between IFN-alpha-induced anti-viral and growth signaling pathways. , 1999, Journal of immunology.

[111]  M. May,et al.  Signal transduction through NF-kappa B. , 1998, Immunology today.

[112]  K C Zoon,et al.  Interferons and their actions. , 1987, Annual review of biochemistry.

[113]  M. Hanley,et al.  Protein kinase Cs. Coping with a growing family. , 1987, Nature.